Signos Secures $20 Million Funding to Expand AI-Driven Weight Loss Solutions in Partnership with Dexcom
Signos has secured $20 million in funding to enhance its AI-driven glucose monitoring system, which aims to capitalize on the growing demand for weight loss solutions linked to GLP-1 medications. This partnership with Dexcom could significantly increase its market presence as obesity rates rise in the U.S.